Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Zhang, Rui ^a   Zhao, Liancheng ^b   Liang, Lirong ^c   Xie, Gaoqiang ^d   Wu, Yangfeng ^a,d,e  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b FUWAI HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

^e GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

Dyslipidemia; Gender disparity; Goal attainment; Lipid lowering treatment; Patient

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID DERIVATIVE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMORBIDITY; DIET RESTRICTION; DYSLIPIDEMIA; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FAMILY HISTORY; FEMALE; GOAL ATTAINMENT; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; SEX DIFFERENCE; SOCIAL STATUS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861477361     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-59     Document Type: Article

References (32)

1. Preventing chronic diseases in China. Wang L, Kong L, Wu F, Bai Y, Burton R, Lancet 2005 366 1821 1824 10.1016/S0140-6736(05)67344-8 16298221 (Pubitemid 41642648)
2. Major causes of death among men and women in China. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, et al. N Engl J Med 2005 353 1124 1134 10.1056/NEJMsa050467 16162883 (Pubitemid 41317435)
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering, Lancet 1994 344 1383 1389 7968073
4. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, et al. JAMA 2004 292 1307 1316 10.1001/jama.292.11. 1307 15337732 (Pubitemid 39223221)
5. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Amarenco P, Labreuche J, Lancet Neurol 2009 8 453 463 10.1016/S1474-4422(09)70058-4 19375663
6. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al. Lancet 2005 366 1267 1278 16214597
7. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ, Circulation 2005 111 488 493 10.1161/01.CIR.0000153859.66086.85 15687138 (Pubitemid 40204434)
8. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S, JAMA 1997 277 1281 1286 10.1001/jama.1997.03540400031027 9109465 (Pubitemid 27194351)
9. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Ansell BJ, Fonarow GC, Maki KC, Dicklin MR, Bell M, Davidson MH, Am Heart J 2006 152 976 981 10.1016/j.ahj.2006.05.013 17070174 (Pubitemid 44637134)
10. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrieres J, Verdejo J, Chiang CW, Am Heart J 2009 158 860 866 10.1016/j.ahj.2009.08.009 19853709
11. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P, Heart 2010 96 1744 1749 10.1136/hrt.2010.196170 20956490
12. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Pearson TA, Laurora I, Chu H, Kafonek S, Arch Intern Med 2000 160 459 467 10.1001/archinte.160.4.459 10695686 (Pubitemid 30112269)
13. The second multi-center survey of dyslipidemia management in China:goal attainment rate and related factors. Wu YF, J Chin Cardiol 2007 35 420 427
14. Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study. Kim HS, Wu Y, Lin SJ, Deerochanawong C, Zambahari R, Zhao L, Zhang Q, Yan P, Curr Med Res Opin 2008 24 1951 1963 10.1185/03007990802138731 18547466
15. Implications for recent clinical trials for the National Cholesterol Education Program Adult Treatment PanelIII guidelines. Grundy SM, Cleeman JI, Merz CN, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Circulation 2004 110 227 239 10.1161/01.CIR.0000133317.49796.0E 15249516 (Pubitemid 38924592)
16. Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults in 2007. J Chin Cardiol 2007 35 390 419
17. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton PK, Circulation 2004 110 405 411 10.1161/01.CIR.0000136583.52681.0D 15238453 (Pubitemid 38993849)
18. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. Arca M, Vega GL, Grundy SM, JAMA 1994 271 453 459 10.1001/jama.1994.03510300059039 8295321 (Pubitemid 24043876)
19. Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy. Karjalainen A, Heikkinen J, Savolainen MJ, Backstrom AC, Kesaniemi YA, Arterioscler Thromb Vasc Biol 2000 20 1101 1106 10.1161/01.ATV.20.4.1101 10764680 (Pubitemid 30207589)
20. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Jones P, Kafonek S, Laurora I, Hunninghake D, Am J Cardiol 1998 81 582 587 10.1016/S0002-9149(97)00965-X 9514454 (Pubitemid 28182422)
21. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL, Circulation 2005 111 499 510 10.1161/01.CIR.0000154568.43333.82 15687140 (Pubitemid 40204436)
22. Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES. Muennig P, Sohler N, Mahato B, Prev Med 2007 45 35 40 10.1016/j.ypmed.2007.04.005 17521717 (Pubitemid 47001479)
23. Social determinants of cardiac disease biomarkers: investigating a Swedish male cohort at ages 50 and 70. Khanolkar A, Vagero D, Koupil I, J Epidemiol Commun Health 2011 65 119
24. Persistence of use of lipid-lowering medications: a cross-national study. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J, JAMA 1998 279 1458 1462 10.1001/jama.279.18.1458 9600480 (Pubitemid 28228203)
25. Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. Brown AF, Gross AG, Gutierrez PR, Jiang L, Shapiro MF, Mangione CM, J Am Geriatr Soc 2003 51 665 670 10.1034/j.1600-0579.2003.00211.x 12752842 (Pubitemid 36541431)
26. Clinical implications of pharmacogenetic variation on the effects of statins. Maggo SD, Kennedy MA, Clark DW, Drug Saf 2011 34 1 19 10.2165/11584380-000000000-00000 21142270
27. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin. Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D, Atherosclerosis 1997 129 231 239 10.1016/S0021-9150(96)06031-5 9105566 (Pubitemid 27135325)
28. Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Pedro-Botet J, Schaefer EJ, Bakker-Arkema RG, Black DM, Stein EM, Corella D, Ordovas JM, Atherosclerosis 2001 158 183 193 10.1016/S0021-9150(01)00410-5 11500190 (Pubitemid 32735483)
29. Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia. Ojala JP, Helve E, Ehnholm C, Aalto-Setala K, Kontula KK, Tikkanen MJ, J Intern Med 1991 230 397 405 10.1111/j.1365-2796. 1991.tb00464.x 1940775
30. Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia. De Knijff P, Stalenhoef AF, Mol MJ, Gevers LJ, Smit J, Erkelens DW, Schouten J, Frants RR, Havekes LM, Atherosclerosis 1990 83 89 97 10.1016/0021-9150(90)90134-5 2390138 (Pubitemid 20210749)
31. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J, Metabolism 1993 42 895 901 10.1016/0026-0495(93)90066-W 8345800 (Pubitemid 23207120)
32. Center for health statistic and information, china: An analysis report of national health services survey in China, 2008, Peking Union Medical College Press 2009